A 55-year-old woman with newly diagnosed Takayasu arteritis was followed for 7 years, during which time she underwent bare metal stenting, drug eluting stenting and coronary bypass grafting for critical coronary and renal artery stenoses. Interventions were initially successful but restenosis occurred within 24 months for all modalities. In contrast, native vessel disease was largely stable after the introduction of immunosuppressive therapy. We advocate a conservative revascularization approach in Takayasu arteritis in the absence of critical end organ ischemia and early optimization of medical therapy.
A 55-year-old hypertensive woman of Indian heritage and no previously known vascular disease was shown to have bilateral renal artery stenosis on ultrasound and referred for renal angiography with a view to stenting. Her only medication was lercanidipine 10 mg daily and her resting blood pressure was 140/90 mmHg. She was a non-smoker, had normal cholesterol and fasting blood glucose and no family history of early-onset atherosclerosis. Creatinine was in the normal range.
Angiography confirmed bilateral ostial renal artery stenosis of 70-90% as shown in Figure 1 . The lesions were successfully stented with bare metal stents, 6 9 15 mm Palmaz Genesis (Cordis, Johnson & Johnson Co., Miami Lakes, FL, USA) and 7 9 18 mm Herculink Plus (Guidant/Abbott Vascular, Temecula, CA, USA). Blood pressure normalized post-procedure and lercanidipine was withdrawn. She was treated with clopidogrel for 4 weeks and long-term aspirin.
At 18 months follow-up the patient was again noted to be hypertensive with ultrasound and angiography confirming bilateral renal artery in-stent restenosis of 50-60%. This was managed conservatively. Imaging also demonstrated non-critical lesions of the abdominal aorta and the left iliac artery.
Two years after renal artery stenting she presented with unstable angina. Coronary angiography revealed 99% stenosis of the ostial left anterior descending (LAD) artery and 100% stenosis of the dominant right coronary artery (RCA). The circumflex artery was free of significant disease. She underwent successful drug eluting stenting to the culprit ostial LAD lesion (zotarolimus eluting Endeavour 3 9 15 mm stent; Medtronic Vascular, Santa Rosa, CA, USA). Dual antiplatelet therapy was reinstated in addition to medical therapy for presumed aggressive atherosclerotic disease.
Four months after coronary stenting, she represented with limiting exertional angina. Angiography demonstrated a 90% ostial LAD in-stent restenosis with extension to the ostium of the first diagonal as shown in Figure 2 . Vasculitic disease was suspected at this time and coronary bypass surgery was performed with a sequential saphenous vein graft (SVG) to the first diagonal and distal LAD and a single SVG to the distal RCA. Vein grafts were used in preference to arterial grafts as they were thought to be less likely to develop vasculitis and graft stenosis. 1 Further imaging showed diffuse disease, including complete occlusion of the coeliac axis and superior mesenteric artery (SMA). 50-80% lesions were demonstrated in the mid-to distal aorta, inferior mesenteric, subclavian, brachiocephalic and left iliac arteries. Images from a computed tomography (CT) aortogram are presented in Figure 3 . The diagnosis of Takayasu arteritis was made 2 months after surgery on the basis of typical radiographic findings, subclavian bruits and blood pressure gradient of 15 mmHg between arms as per the American College of Rheumatology (ACR) classification criteria. 2 She did not report a history of constitutional or rheumatologic symptoms and a vasculitic blood screen, including antinuclear antibodies (ANA), double-stranded DNA (dsDNA), antineutrophil cytoplasmic antibodies (ANCA), extractable nuclear antigens (ENA), was negative other than mildly elevated Creactive protein (CRP) of 8 mg/L (normal < 3 mg/L) and erythrocyte sedimentation rate (ESR) of 43 mm/h (normal < 20 mm/h). A F-fluorodeoxyglucose positron emission tomography (FDG-PET) scan did not reveal focal vascular uptake.
Immunosuppressive therapy with prednisone and methotrexate was commenced 6 months after bypass surgery and over the subsequent 2 years inflammatory markers remained mildly elevated. They subsequently fell to near normal levels with azathioprine as a single agent. Warfarin was commenced to potentially minimize the risk of future thrombotic events but was discontinued after 1 month because of intolerance. Two years after coronary bypass surgery the patient represented with limiting exertional angina. Angiography demonstrated a critical 95% stenosis of the graft to LAD and a 50-70% stenosis of the graft to the first diagonal. The RCA graft was patent. Balloon angioplasty was successfully performed to the LAD graft as well as the ostial in-stent lesion in the native LAD. The native LAD lesion was not restented to avoid involvement of the left main stem and presumed high likelihood of restenosis.
The patient has been followed up for 3 years since the most recent intervention. She has been well with no ischemic coronary or mesenteric symptoms. Imaging of the aorta, mesenteric, renal and iliac vessels has shown no disease progression. Exercise stress echocardiograms have been negative. Creatinine and inflammatory markers have remained in the normal range and she is normotensive. Current medications include azathioprine, aspirin, clopidogrel, simvastatin, ezetimibe, lercanidipine, metoprolol and nicorandil. We do not plan to conduct further routine imaging surveillance in the absence of end-organ dysfunction.
DISCUSSION
Takayasu arteritis is a rare chronic large vessel vasculitis most prevalent in young women of Asian descent. 2 The aorta, subclavian, carotid, renal and pulmonary vessels are frequently affected. The coronary arteries are involved in <10% of cases. The currently accepted criteria to diagnose arteritis and define disease activity are based on clinical and imaging findings. A patient who meets three or more of the six ACR 1990 criteria is classified as having Takayasu arteritis. 2 The National Institutes of Health (NIH) classifies arteritis as being active if progression occurs in at least two of the following four domains:
4 systemic inflammation (e.g., fevers, constitutional and/or musculoskeletal symptoms); ESR; vascular ischemia; and typical angiographic features. FDG-PET has been trialed as a novel modality to diagnose flares of Takayasu arteritis using the ACR and NIH classification systems as the reference standard. A recent case series reported a sensitivity of 92.6% and specificity of 91.7% for disease activity. 5 Our patient met NIH criteria for active Takayasu arteritis based on an elevated ESR and recurrent in-stent restenosis. The negative FDG-PET scan, however, suggests the absence of widespread vascular inflammation and may explain the lack of significant native vessel disease progression during patient follow-up.
Arterial stenosis is a well-recognized complication of Takayasu arteritis and revascularization is usually indicated in the presence of critical ischemia. 6 Stenting has been shown in a case series to be effective in restoring patency in the short-term with successful revascularization rates between 80% and 93%. [7] [8] [9] [10] Long-term data is limited with restenosis rates in small cohorts for coronary, supra-aortic, renal arteries and the aorta, varying greatly from 8% to 71%. 6, 7, 9, [11] [12] [13] [14] [15] These rates compare with 11-37% [16] [17] [18] for non-vasculitic coronary and renal artery lesions. Surgical bypass stenosis rates in Takayasu arteritis are reported to be lower than those for stents at 8-36%. 6, [10] [11] [12] A rate of 50% was described for a subgroup of 12 coronary artery bypass patients. 10 Restenosis may be influenced by stent type and degree of disease activity. Drug-eluting stents have theoretical immunosuppressive and antiproliferative advantages 19 but their use has been reported in just eight cases in Takayasu arteritis, all in native coronary arteries. Two restenosed and six remained patent at shortterm follow-up. 3, 19 Restenosis rates have been shown in case series to be lower when the disease is inactive at the time of procedure 11, 12 and when a course of glucocorticoids and immunosuppressives is prescribed after the procedure. 11 Some authors have proposed that balloon angioplasty is preferable to stenting but case series data does not demonstrate a consistent difference in restenosis rates. 7, 11, 13, 14 New-generation drug-eluting balloons and biodegradable stents may have a role to play in improving revascularization outcomes in the future. 20 In our patient, bare metal stents, drug eluting stents and SVGs achieved initial success but stenosis occurred for all interventions within 24 months. This is in keeping with the literature which reports acute revascularization success rates exceeding 80% but high rates of stent and graft stenosis in most studies on longer-term follow-up. Active medical treatment with prednisone, methotrexate and azathioprine failed to prevent stenosis of coronary bypass grafts. In contrast with these outcomes, there was no significant progression of native vessel disease in the 5 years of patient follow-up after the introduction of immunosuppressive therapy.
CONCLUSION
The literature and our case report supports the view that in patients with Takayasu arteritis, lesions in the renal, mesenteric and coronary circulation should be managed conservatively in the absence of critical end-organ ischemia. Due to the poor prognosis with transcatheter and surgical revascularization procedures, clinicians should consider vasculitis in younger patients with unexplained widespread vascular disease to allow the early introduction of immunosuppressive therapy.
